The U.S. FDA is launching a program under which its commissioner can issue vouchers to companies he finds are aligned with national priorities to shorten their review time for a drug application ...

KalVista Pharmaceuticals' said on Friday that the U.S. Food and Drug Administration had extended the review of its drug for a type of hereditary swelling disorder due to heavy workload and limited ...

The regulator said on Tuesday that the commissioner would determine whether a company aligns with health priorities such as delivering innovative medicines, addressing a health crisis or unmet ...

Reuters FILE PHOTO: A Gilead Sciences, Inc. logo is seen outside the company headquarters in Foster City, California, U.S. May 1, 2018. REUTERS/Stephen Lam ...

The FDA has stopped new clinical trials that export American citizens’ living cells from the U.S. to “China and other hostile countries for genetic engineering and subsequent infusion” back ...

(Reuters) -The U.S. FDA is launching a program under which its commissioner can issue vouchers to companies he finds are aligned with national priorities to shorten their review time for ...

Special Report: Optiscan has signed an exclusive five-year collaboration with US-based Long Grove Pharmaceuticals to develop new applications for AK-FLUOR, a contrast agent used with Optiscan’s ...

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug Administration to be used to prevent HIV.

The FDA inspected Gongora USA Corp., located at 355 K St. Suite F, Chula Vista, CA, from Nov. 14 to 15, 2024, following an earlier inspection between December 2020 and January 2021.

Weaver Nut Company has recalled all semi-sweet chocolate nonpareils due to potential undeclared milk allergens. The FDA announced the recall on June 18, 2025, affecting specific lot codes ...

This week's project features a coffee mug with a base and handle cast from pewter. Grey powder added to the glue is leftover pewter dust from sanding the pewter parts, giving color to the glue ...

For the new program, the FDA will issue a limited number of “national priority vouchers” to companies “aligned with U.S. national priorities,” the agency said in a statement.